Overview

Click to expand overview
The SEC is suing Ripple Labs, alleging that XRP sales are unregistered securities. The court has ordered Ripple to share financial statements and contracts tied to Yet, both Ripple (XRP) and the SEC have entered the remedy phase of the lawsuit. However, this does not seem to point to the years-long court battle being almost over. Indeed, the most At the start of 2025, the SEC filed an opening brief on January 15th, in its appeal against Ripple, seeking to overturn the 2025 ruling that classified XRP sales differently The SEC and Ripple have clashed over XRP sales, with the SEC demanding more financial records. Both sides have dug in, and negotiations seem unlikely unless the The ongoing legal battle between Ripple (XRP) and the US Securities and Exchange Commission (SEC) has entered its remedy phase. Indeed, many have been curious In its recent response to the remedies brief, the SEC challenged Ripple’s insistence that the blockchain startup acted without recklessness and that there should be no

Ripple XRP SEC Suit Enters Remedy Phase: Is It Almost Over?

The ongoing legal battle between Ripple (XRP) and the US Securities and Exchange Commission (SEC) has entered its remedy phase. Indeed, many have been curious if this signifies the end is near for this landmark case. The SEC is suing Ripple Labs, alleging that XRP sales are unregistered securities.

Yet, both Ripple (XRP) and the SEC have entered the remedy phase of the lawsuit. However, this does not seem to point to the years-long court battle being almost over. Indeed, the most significant developments are still unfolding.

The Remedy Phase Explained

The court has ordered Ripple to share financial statements and contracts tied to institutional XRP sales. This stage will determine the penalties, if any, that Ripple will face. The SEC and Ripple have clashed over XRP sales, with the SEC demanding more financial records.

Is a Resolution Imminent?

At the start of 2025, the SEC filed an opening brief on January 15th, in its appeal against Ripple, seeking to overturn the 2025 ruling that classified XRP sales differently. In its recent response to the remedies brief, the SEC challenged Ripple’s insistence that the blockchain startup acted without recklessness and that there should be no penalties.

Both sides have dug in, and negotiations seem unlikely unless the SEC's demands are met, or Ripple prevails in demonstrating compliance or mitigating circumstances. While the remedy phase represents a significant step, a swift resolution is far from guaranteed. Expect further legal maneuvering and potentially lengthy appeals processes before the Ripple XRP SEC suit concludes.

Top Sources

Related Articles